ANGO AngioDynamics, Inc.
$15.27▲ +0.20%
Healthcare
Other
After hours
$15.41▲ +0.92%
Sep 11, 7:30 PM ET
Volume 342.0K
Avg Volume (10D) 336.9K
Key Metrics & Fundamentals
Market Cap
$631.15M
P/E Ratio
–
Div Yield
–%
52W Range
9.39 - 16.29
% vs 50 MA
3.32%
% vs 200 MA
24.15%
RSI-14
48.5
MACD Histogram
-0.1500
Beta (1Y vs SPY)
0.98
Free Cash Flow
$17.04M
Gross Rev
$86.61M
Gross Profit
$46.77M
EBITDA
$4.77M
COGS
$39.83M
Operating Exp
$52.29M
Operating Income
-$5.51M
EBIT
-$5.51M
Pretax Income
-$11.04M
Net Income
-$11.41M
EPS (Diluted)
-0.27
Price & Volume History
Loading chart…
Recent News
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
Zacks · Aug 13, 2026 3:30 PM
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
MarketBeat · Aug 11, 2026 11:04 PM
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
Zacks · Aug 6, 2026 6:16 PM
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
Zacks · Aug 6, 2026 6:13 PM
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
Zacks · Aug 6, 2026 6:07 PM
AngioDynamics to Participate in Upcoming Investor Conferences
Business Wire · Jul 28, 2026 12:30 PM
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript
Motley Fool · Jul 21, 2026 7:47 PM
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
Zacks · Jul 15, 2026 2:29 PM
AngioDynamics, Inc. Q4 2026 Earnings Call Summary
Moby · Jul 15, 2026 12:30 PM
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
GuruFocus.com · Jul 14, 2026 7:00 PM
Financial Overview - Income Statement
Quarterly
May 2026
See ANGO's money flow as a full page
Social Sentiment
No Reddit posts found for ANGO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.